Moreover, our results about SOCS3 are in agreement with previous studies that have hypothesised the relationship between the methylation of the SOCS3 promoter and poor prognosis in GBM [17], and its low expression and worse response in other cancers [19,20]. Here, SOCS3 is linked to glioblastoma.